A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study Meeting Abstract
| Authors: | Yarchoan, M.; Cope, L.; Anders, R. A.; Noonan, A.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A.; He, A. R.; Abou-Alfa, G.; Spencer, K.; Kim, E.; Xavier, S.; Ruggieri, A.; Davis, S. L.; McRee, A.; Kunk, P.; Zhu, Q.; Wang-Gillam, A.; Poklepovic, A.; Chen, H.; Sharon, E.; Lesinski, G. B.; Azad, N. |
| Abstract Title: | A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059302169 |
| DOI: | 10.1158/1538-7445.Am2020-ct043 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT043 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
